Protein Assays Market Snapshot
| Study Period: | 2018 - 2026 |
| Base Year: | 2021 |
| Fastest Growing Market: | Asia Pacific |
| Largest Market: | North America |
| CAGR: | 10.9 % |
|
Need a report that reflects how COVID-19 has impacted this market and its growth?
Market Overview
The Protein Assays Market is expected to register a CAGR of 10.9% during the forecast period. Protein assay is a widely used method to determine the amount or concentration of a specific protein or an array of different proteins sample. Estimation of protein concentration is necessary for cell biology, molecular biology, protein purification, electrophoresis, and other research applications. A wide variety of protein assays available which can be used based on considering their suitability for the application. Some of the protein assays are Bicinchoninic Acid (BCA), Bradford, Folin-Lowry, Kjeldahl and Ultraviolet absorption. Protein assays are widely used in the diagnosis of the diseases such as cancer, liver, kidney, and other infectious diseases, and in the drug discovery & development process.
According to the World Health Organization (WHO), globally, cancer is a leading cause of death, accounting for an estimated 9.6 million deaths in the year 2018. Increasing incidence of chronic diseases like cardiovascular, neurological and other infectious diseases, and increasing investment in R&D activities by the biotech and pharmaceutical companies coupled with the increased funding by governments for proteomics research are the key driving factors in protein assays market.
Scope of the Report
Protein assays are widely used method to determine the presence or concentration of a specific protein or an array of different proteins sample. Protein Assays Market is segmented By Product Type, Application, End User and Geography.
| By Product Type | |
| Kits | |
| Reagents | |
| Instruments & Accessories |
| By Application | |
| Drug Discovery and Development | |
| Disease Diagnosis | |
| Other Applications |
| By End User | |
| Pharmaceutical & Biotechnology Industries | |
| Hospitals and Clinics | |
| Other End Users |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Key Market Trends
Pharmaceutical & Biotechnology Companies Segment is Expected to Hold a Major Market Share in the Protein Assays Market
- According to the publication by Pharmaceuticals Research and Manufacturers of America and the Association of the British Pharmaceutical Industry, estimates worldwide pharmaceutical R&D spend has grown from 108.1 billion USD in the year 2006 to 156.7 billion USD in the year 2016, this, in turn, has led to growth in protein assays market.
- Pharmaceutical & Biotechnology companies segment holds a significant market share in the protein assays market and is anticipated to show a similar trend over the forecast period due to growing utilization in manufacturing and drug development and discovery process.
- Increasing adoption of protein assays used to diagnose cancer, immune system diseases, bone marrow diseases, and other infectious diseases and technological advancements in protein assay techniques are also driving the market.
To understand key trends, Download Sample Report
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a major market share in the global protein assays market due to increasing investment in R&D activities by the biotech and pharmaceutical companies coupled with the increased funding by governments and presence of a large number of biotech and pharmaceutical companies in this region. According to the publication by Pharmaceuticals Research and Manufacturers of America, in the year 2017, United States has spent 71.4 million USD on pharmaceutical research and development (R&D) which has increased compared to previous years. Furthermore, technological advancements in protein assay techniques and the presence of well-established healthcare infrastructure are also fueling the growth of the overall regional market to a large extent.
To understand geography trends, Download Sample Report
Competitive Landscape
The Protein Assays Market is fragmented competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Thermo Fisher Scientific, Bio-Rad Laboratories, Inc, Merck & Co., Inc (Merck KGaA), Cell Signaling Technology, Inc, Danaher, F. Hoffmann-La Roche Ltd, PerkinElmer Inc, Promega Corporation, Abcam Plc and Qiagen.
Recent Development
- In March 2022, Biognosys launched an expanded suite of proteomics platforms that provide pharmaceutical and diagnostics customers with deep biological insights across the entire R&D pipeline, from early-stage discovery to clinical settings.
- In January 2022, Amgen entered into a partnership with Generate Biomedicines to discover and create protein therapeutics for five targets across several therapeutic areas and multiple modalities with an early investment of USD 1.9 billion-plus.
Table of Contents
1. INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidence of Chronic and Infectious Diseases
4.2.2 Technological Advancements in Protein Assay Techniques
4.2.3 Increasing Expenditure on Pharmaceutical and Biological Research and Development
4.3 Market Restraints
4.3.1 High Cost of Multiplex Assay Equipment
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Kits
5.1.2 Reagents
5.1.3 Instruments & Accessories
5.2 By Application
5.2.1 Drug Discovery and Development
5.2.2 Disease Diagnosis
5.2.3 Other Applications
5.3 By End User
5.3.1 Pharmaceutical & Biotechnology Industries
5.3.2 Hospitals and Clinics
5.3.3 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Thermo Fisher Scientific
6.1.2 Bio-Rad Laboratories, Inc
6.1.3 Merck KGaA
6.1.4 Cell Signaling Technology, Inc
6.1.5 Danaher
6.1.6 F. Hoffmann-La Roche Ltd
6.1.7 PerkinElmer Inc
6.1.8 Promega Corporation
6.1.9 Abcam Plc
6.1.10 Qiagen
*List Not Exhaustive7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Global Protein Assays Market market is studied from 2018 - 2026.
What is the growth rate of Global Protein Assays Market?
The Global Protein Assays Market is growing at a CAGR of 10.9% over the next 5 years.
Which region has highest growth rate in Global Protein Assays Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Global Protein Assays Market?
North America holds highest share in 2021.
Who are the key players in Global Protein Assays Market?
Thermo Fisher Scientific, Bio-Rad Laboratories, Inc, Merck & Co., Inc (Merck KGaA), Cell Signaling Technology, Inc, Danaher are the major companies operating in Global Protein Assays Market.
